Mainstream smoke chemistry and in vitro and in vivo toxicity of the reference cigarettes 3R4F and 2R4F

Beitrage zur Tabakforschung International/ Contributions to Tobacco Research

Volumn 25, Issue 1, 2012, Pages 316-335

  Roemer, Ewald ^a   Schramke, Heike ^a   Weiler, Horst ^b   Buettner, Ansgar ^c   Kausche, Sandra ^b   Weber, Susanne ^b   Berges, An ^a   Stueber, Markus ^b   Muench, Monja ^b   Trelles Sticken, Edgar ^b   Pype, Jan ^a   Kohlgrueber, Karola ^b   Voelkel, Hartmut ^b   Wittke, Sandra ^b  

^a PHILIP MORRIS PRODUCTS S A   (Switzerland)

^b Philip Morris Research Laboratories GmbH   (Germany)

^c Histovia GmbH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

RATTUS; SALMONELLA;

EID: 84858971580     PISSN: 0173783X     EISSN: 16129237     Source Type: Journal    
DOI: 10.2478/cttr-2013-0912     Document Type: Article

References (51)

1. Chepiga, T.A., M.J. Morton, P.A. Murphy, J.T. Avalos, B.R. Bombick, D.J. Doolittle, M.F. Borgerding, and J.E. Swauger: A comparison of the mainstream smoke chemistry and mutagenicity of a representative sample of the US cigarette market with two Kentucky reference cigarettes (K1R4F and K1R5F); Food Chem. Toxicol. 38 (2000) 949-962.
2. Werley, M.S., S.A. Freelin, S.E. Wrenn, B. Gerstenberg, E. Roemer, H. Schramke, E. Van Miert, P. Vanscheeuwijck, S. Weber, and C.R. Coggins: Smoke chemistry, in vitro and in vivo toxicology evaluations of the electrically heated cigarette smoking system series K; Regul. Toxicol. Pharmacol. 52 (2008) 122-139.
3. Chen, P.X. and S.C. Moldoveanu: Mainstream smoke chemical analyses for 2R4F Kentucky reference cigarette; Beitr. Tabakforsch. Int. 20 (2003) 448-458.
4. Counts, M.E., F.S. Hsu, and F.J. Tewes: Development of a commercial cigarette "market map" comparison methodology for evaluating new or non-conventional cigarettes; Regul. Toxicol. Pharmacol. 46 (2006) 225-242.
5. Adam, T., S. Mitschke, T. Streibel, R.R. Baker, and R. Zimmermann: Puff-by-puff resolved characterisation of cigarette mainstream smoke by single photon ionisation (SPI)-time-of-flight mass spectrometry (TOFMS): comparison of the 2R4F research cigarette and pure Burley, Virginia, Oriental and Maryland tobacco cigarettes; Anal. Chim. Acta 572 (2006) 219-229.
6. Intorp, M., S. Purkis, M. Whittaker, and W. Wright: Determination of "Hoffmann Analytes" in Cigarette Mainstream Smoke. The Coresta 2006 Joint Experiment; Beitr. Tabakforsch. Int. 23 (2009) 161-202.
7. Rickert, W.S., A.H. Trivedi, R.A. Momin, W.G. Wright, and J.H. Lauterbach: Effect of smoking conditions and methods of collection on the mutagenicity and cytotoxicity of cigarette mainstream smoke; Toxicol. Sci. 96 (2007) 285-293.
8. Roemer, E., T.H. Ottmueller, V. Zenzen, S. Wittke, F. Radtke, I. Blanco, and R.A. Carchman: Cytotoxicity, mutagenicity, and tumorigenicity of mainstream smoke from three reference cigarettes machine-smoked to the same yields of total particulate matter per cigarette; Food Chem. Toxicol. 47 (2009) 1810-1818.
9. Roemer, E., R. Stabbert, K. Rustemeier, D.J. Veltel, T.J. Meisgen, W. Reininghaus, R.A. Carchman, C.L. Gaworski, and K.F. Podraza: Chemical composition, cytotoxicity and mutagenicity of smoke from US commercial and reference cigarettes smoked under two sets of machine smoking conditions; Toxicology 195 (2004) 31-52.
10. Schramke, H., T.J. Meisgen, F.J. Tewes, W. Gomm, and E. Roemer: The mouse lymphoma thymidine kinase assay for the assessment and comparison of the mutagenic activity of cigarette mainstream smoke particulate phase; Toxicology 227 (2006) 193-210.
11. Chen, J., R. Higby, D. Tian, D. Tan, M.D. Johnson, Y. Xiao, K.J. Kellar, S. Feng, and P.G. Shields: Toxicological analysis of low-nicotine and nicotine-free cigarettes; Toxicology 249 (2008) 194-203.
12. Gaworski, C.L., R. Lemus-Olalde, and E.L. Carmines: Toxicological evaluation of potassium sorbate added to cigarette tobacco; Food Chem. Toxicol. 46 (2008) 339-351.
13. Newland, N. and A. Richter: Agents associated with lung inflammation induce similar responses in NCI-H292 lung epithelial cells; Toxicol. in vitro 22 (2008) 1782-1728.
14. Carter, C.A. and J.T. Hamm: Multiplexed quantitative high content screening reveals that cigarette smoke condensate induces changes in cell structure and function through alterations in cell signaling pathways in human bronchial cells; Toxicology 261 (2009) 89-102.
15. Higuchi, M.A., J. Sagartz, W.K. Shreve, and P.H. Ayres: Comparative subchronic inhalation study of smoke from the 1R4F and 2R4F reference cigarettes; Inhal. Toxicol. 16 (2004) 1-20.
16. ISO 3308: Routine analytical cigarette smoking machine-Definitions and standard conditions. International Organization for Standardization, Geneva, Switzerland, 2000.
17. Health Canada: Determination of 'tar', nicotine and carbon monoxide in mainstream smoke. Health Canada-Official Method 1999.
18. Marian, C., R.J. O'Connor, M.V. Djordjevic, V.W. Rees, D.K. Hatsukami, and P.G. Shields: Reconciling human smoking behavior and machine smoking patterns: implications for understanding smoking behavior and the impact on laboratory studies; Cancer Epidemiol. Biomarkers Prev. 18 (2009) 3305-3320.
19. Hammond, D., G.T. Fong, K.M. Cummings, and A. Hyland: Smoking topography, brand switching, and nicotine delivery: results from an in vivo study; Cancer Epidemiol. Biomarkers Prev. 14 (2005) 1370-1375.
20. Hammond, D., G.T. Fong, K.M. Cummings, R.J. O'Connor, G.A. Giovino, and A. McNeill: Cigarette yields and human exposure: a comparison of alternative testing regimens; Cancer Epidemiol. Biomarkers Prev. 15 (2006) 1495-1501.
21. ISO 3402: Tobacco and tobacco products-Atmosphere for conditioning and testing. International Organization for Standardization, Geneva, Switzerland, 1999.
22. Radtke, F., M. Schmickler, W. Ochel, and H. Schaffernicht: Pumpenanordnung. Patent EP1832745 (A1) In Office, E.P. (ed.), Germany, 2007.
23. ISO 4387: Determination of total and nicotine-free dry particulate matter using routine analytical smoking machine. International Organization for Standardization, Geneva, Switzerland, 1991.
24. ISO 10315: Cigarettes-Determination of nicotine in smoke condensate-Gas chromatographic method (2nd ed.). International Organization for Standardization, Geneva, Switzerland, 2000.
25. ISO 8454: Cigarettes-Determination of carbon monoxide in the vapour phase of cigarette smoke-NDIR method (3rd ed.). International Organization for Standardization, Geneva, Switzerland, 2007.
26. CORESTA: Recommended Method No. 74-Determination of selected carbonyls in mainstream cigarette smoke by high performance liquid chromatography (HPLC). Cooperation Centre for Scientific Research Relative to Tobacco, 2011.
27. CORESTA: Recommended Method No. 70-Determination of selected volatile organic compounds in the mainstream smoke of cigarettes-gas chromatography-mass spectrometry method. Co-operation Centre for Scientific Research Relative to Tobacco, 2010.
28. Diekmann, J., A. Wittig, and R. Stabbert: Gas chromatographic-mass spectrometric analysis of acrylamide and acetamide in cigarette mainstream smoke after on-column injection; J. Chromatogr. Sci. 46 (2008) 659-663.
29. Diekmann, J., M. Douda, and K. Rustemeier: Rapid and sensitive method for the determination of propylene oxide in cigarette mainstream smoke by gas chromatography-mass spectrometry; J. Chromatogr. Sci. 44 (2006) 32-34.
30. Stabbert, R., K.H. Schaefer, C. Biefel, and K. Rustemeier: Analysis of aromatic amines in cigarette smoke; Rapid Commun. Mass. Spectrom. 17 (2003) 2125-2132.
31. CORESTA: Recommended Method (3rd Draft): The determination of nitric oxide in mainstream smoke of cigarettes by chemiluminescent analysis; Available at (accessed January 2012): http://legacy.library.ucsf.-edu/tid/vpe43d00/pdf;jsessionid=BEB3E72646 C743124370F7007FA332D8.tobacco03.
32. Mottier, N. and F. Jeanneret: Evaluation of two derivatization reagents for the determination by LC-MS/MS of ammonia in cigarette mainstream smoke; J. Agric. Food Chem. 59 (2011) 92-97.
33. Wagner, K.A., N.H. Finkel, J.E. Fossett, and I.G. Gillman: Development of a quantitative method for the analysis of tobacco-specific nitrosamines in mainstream cigarette smoke using isotope dilution liquid chromatography/electrospray ionization tandem mass spectrometry; Anal. Chem. 77 (2005) 1001-1006.
34. Maron, D.M. and B.N. Ames: Revised methods for the Salmonella mutagenicity test; Mutat. Res. 113 (1983) 173-215.
35. Cole, J., W.J. Muriel, and B.A. Bridges: The mutagenicity of sodium fluoride to L5178Y [wild-type and TK+/-(3.7.2c)] mouse lymphoma cells; Mutagenesis 1 (1986) 157-167.
36. Gaworski, C.L., H. Schramke, J. Diekmann, T.J. Meisgen, F.J. Tewes, D.J. Veltel, P.M. Vanscheeuwijck, N. Rajendran, M. Muzzio, and H.J. Haussmann: Effect of filtration by activated charcoal on the toxicological activity of cigarette mainstream smoke from experimental cigarettes; Inhal. Toxicol. 21 (2009) 688-704.
37. ISO 3308: Routine analytical cigarette-smoking machine-Definitions and standard conditions; International Organization for Standardization, Geneva, Switzerland, 2000.
38. Young, J.T.: Histopathologic examination of the rat nasal cavity; Fundam. Appl. Toxicol. 1 (1981) 309-312.
39. Lewis, D.J.: Factors affecting the distribution of tobacco smoke-induced lesions in the rodent larynx; Toxicol. Lett. 9 (1981) 189-194.
40. Carmines, E.L., C.L. Gaworski, A.S. Faqi, and N. Rajendran: In utero exposure to 1R4F reference cigarette smoke: evaluation of developmental toxicity; Toxicol. Sci. 75 (2003) 134-147.
41. Vanscheeuwijck, P.M., A. Teredesai, P.M. Terpstra, J. Verbeeck, P. Kuhl, B. Gerstenberg, S. Gebel, and E.L. Carmines: Evaluation of the potential effects of ingredients added to cigarettes. Part 4: subchronic inhalation toxicity; Food Chem. Toxicol. 40 (2002) 113-131.
42. Counts, M.E., M.J. Morton, S.W. Laffoon, R.H. Cox, and P.J. Lipowicz: Smoke composition and predicting relationships for international commercial cigarettes smoked with three machine-smoking conditions; Regul. Toxicol. Pharmacol. 41 (2005) 185-227.
43. Okuwa, K., M. Tanaka, Y. Fukano, H. Nara, Y. Nishijima, and T. Nishino: In vitro micronucleus assay for cigarette smoke using a whole smoke exposure system: a comparison of smoking regimens; Exp. Toxicol. Pathol. 62 (2009) 433-40.
44. Roemer, E. and R.A. Carchman: Limitations of cigarette machine smoking regimens; Toxicol. Lett. 203 (2011) 20-27.
45. Terpstra, P.M., A. Teredesai, P.M. Vanscheeuwijck, J. Verbeeck, G. Schepers, F. Radtke, P. Kuhl, W. Gomm, E. Anskeit, and G. Patskan: Toxicological evaluation of an electrically heated cigarette. Part 4: Subchronic inhalation toxicology; J. Appl. Toxicol. 23 (2003) 349-362.
46. Baker, R.R., E.D. Massey, and G. Smith: An overview of the effects of tobacco ingredients on smoke chemistry and toxicity; Food Chem. Toxicol. 42 Suppl. (2004) S53-S83.
47. DiGiovanni, J.: Multistage carcinogenesis in mouse skin; Pharmacol. Ther. 54 (1992) 63-128.
48. Berenblum, I.: The cocarcinogenic action of croton resin; Cancer Res. 1 (1941) 44-48.
49. Belkebir, E., C. Rousselle, C. Duboudin, L. Bodin, and N. Bonvallot: Haber's rule duration adjustments should not be used systematically for risk assessment in public health decision-making; Toxicol. Lett. 204 (2010) 148-155.
50. Tsuji, H., K.M. Lee, K. Yoshino, H. Nakamura, G. Lulham, R. Renne, and H. Yoshimura: Comparison of the physiological and morphological effects of cigarette smoke exposure at comparable weekly doses on Sprague-Dawley rats; Inhal. Toxicol. 23 (2010) 17-32.
51. St Charles, F.K., C.J. Cook, and P.M. Clayton: The linear relationship between cigarette 'tar' and nicotine yields: Regulatory implications for smoke constituent ratios; Regul. Toxicol. Pharmacol. 59 (2011) 143-148.